Influence of hepatitis C virus replication: On splenic lymphoma with villous lymphocytes;Influência da replicação do vírus da hepatite C: Em linfoma esplénico de células vilosas

Acta Medica Portuguesa

Volumn 23, Issue 5, 2010, Pages 941-944

  Nunes, Joana ^a   Tato Marinho, Rui ^a   Raposo, João ^a   Velosa, José ^a  

^a HOSPITAL DE SANTA MARIA   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

FLUDARABINE; PEGINTERFERON; RIBAVIRIN;

ARTICLE; B CELL LYMPHOMA; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LYMPHOCYTE; LYMPHOMA; NONHODGKIN LYMPHOMA; PATHOGENESIS; SPLEEN; SPLENECTOMY; VIRUS INFECTION; VIRUS REPLICATION;

AGED; HEPACIVIRUS; HUMANS; LYMPHOCYTES; LYMPHOMA; MALE; SPLENIC NEOPLASMS; VIRUS REPLICATION;

EID: 78649676148     PISSN: None     EISSN: 16460758     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. PARSONNET J, HANSEN S, RODRIGUEZ L et al: Helicobacter pylori infection and gastric lymphoma. N Engl J Med 1994;330:1267-71
2. GISBERT J, GARCÍA-BUEY L, PAJARES J, et al: Prevalence of Hepatitis C Virus Infection in B-Cell Non-Hodgkin's Lymphoma: Systematic Review and Meta-Analysis. Gastroenterology 2003;125:1723-32
3. ZUCKERMAN E, ZUCKERMAN T, LEVINE AM et al: Hepatitis C virus infection in patients with B-cell non-Hodgkin lymphoma. Ann Intern Med 1997;127:423-8
4. SILVESTRI F, PIPAN C, BARILLARI G et al: Prevalence of hepatitis C virus infection in patients with lymphoproliferative disorders. Blood 1996;87:4296-301
5. MELE A, PULSONI A, BIANCO E et al: Hepatitis C virus and B-cell non-Hodgkin lymphomas: an Italian multicenter case-control study. Blood 2003;102:996-9
6. MATSUO K, KUSANO A, SUGUMAR A, et al: Effect of hepatitis C virus infection on the risk of non-Hodgkin's lymphoma: A meta-analysis of epidemiological studies. Cancer Sci 2004;95:745
7. HERMINE O, LEFRERE F, BRONOWICKI J-P et al: Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection. N Engl J Med 2002;347:89-94 (Pubitemid 34753478)
8. TSUKUMA H, HIYAMA T, TANAKA S et al. Risk factors for hepatocellular carcinoma among patients with chronic liver disease. N Engl J Med 1993;328:1797-80
9. COLLIER J, ZANKE B, MOORE M et al: No Association between Hepatitis C and B-Cell Lymphoma. Hepatology 1999;29:1259-61
10. KAWAMURA Y., IKEDA K., ARASE Y et al: Viral Elimination Reduces Incidence of Malignant Lymphoma in Patients with Hepatitis C. Am J Med 2007;120:1034-41
11. SAADOUN D, SUAREZ F, LEFRERE F et al: Splenic lymphoma with villous lymphocytes, associated with type II cryoglobulinemia and HCV infection: a new entity? Blood 2005;105:74-6
12. SUAREZ F, LORTHOLARY O, HERMINE O et al: Infection-associated lymphomas derived from marginal zone B cells: a model of antigen-driven lymphoproliferation. Blood 2006;107:3034-44
13. MAZZARO C, FRANZIN F, TULISSI P et al: Regression of monoclonal B-cell expansion in patients affected by mixed cryoglobulinemia responsive to alpha-interferon therapy. Cancer 1996;77:2604-13
14. VALLISA D, BERNUZZI P, ARCAINI L et al : Role of antihepatitis C vírus (HCV) treatment in HCV related low-grade, non-Hodgkin's lymphoma: A multicenter Italian experience. J Clin Oncol 2005;23:468-473